These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Immunology of anogenital human papillomavirus (HPV) infection. Tindle RW; Frazer IH Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):370-5. PubMed ID: 1964551 [TBL] [Abstract][Full Text] [Related]
48. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Sillman FH; Sedlis A Obstet Gynecol Clin North Am; 1987 Jun; 14(2):537-58. PubMed ID: 2829084 [TBL] [Abstract][Full Text] [Related]
49. [HPV genital infections + CIN. The immunological patterns, loop electroablation and beta-interferon]. Vitale G; Linciano M; Salamanca S; Ferrari P Minerva Ginecol; 1994 Mar; 46(3):91-4. PubMed ID: 8015705 [TBL] [Abstract][Full Text] [Related]
50. A complicated case of skin cancer in a renal allograft recipient. Gruber SA; Stephanian E; Dunn DL Transplant Sci; 1994 Sep; 4(1):17-9. PubMed ID: 7804692 [No Abstract] [Full Text] [Related]
51. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals. Arany I; Evans T; Tyring SK Sex Transm Infect; 1998 Oct; 74(5):349-53. PubMed ID: 10195031 [TBL] [Abstract][Full Text] [Related]
52. Perianal Buschke-Löwenstein tumour: progressive growth despite immune restoration in a man positive for human immunodeficiency virus. Cusini M; Gaiani F; Girgenti V; Cantoni G; Ramoni S Clin Exp Dermatol; 2010 Jun; 35(4):e163-4. PubMed ID: 20105191 [No Abstract] [Full Text] [Related]
53. Pathogenesis and treatment of human genital papillomavirus infections: a review. Reichman RC; Strike DG Antiviral Res; 1989 Apr; 11(3):109-18. PubMed ID: 2544136 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic phase antibody response to the human papillomavirus type 16 E2 protein is associated with successful treatment of genital HPV lesions with systemic interferon alpha-2b. Stellato G; Paavonen J; Nieminen P; Hibma M; Vilja P; Lehtinen M Clin Diagn Virol; 1997 Feb; 7(3):167-72. PubMed ID: 9126686 [TBL] [Abstract][Full Text] [Related]
55. [Immunologic parameters in patients with acuminata condylomas]. Marzo López MC; Ramírez Bosca A; Montolio Doñate S; Martínez Ojeda L; Castells Rodellas A Med Cutan Ibero Lat Am; 1988; 16(4):273-6. PubMed ID: 2852740 [TBL] [Abstract][Full Text] [Related]
56. Immunologic identification of papillomavirus antigen in condyloma tissues from the female genital tract. Woodruff JD; Braun L; Cavalieri R; Gupta P; Pass F; Shah KV Obstet Gynecol; 1980 Dec; 56(6):727-32. PubMed ID: 6255385 [TBL] [Abstract][Full Text] [Related]
57. Immunology of HPV infection and HPV-associated tumors. Majewski S; Jablonska S Int J Dermatol; 1998 Feb; 37(2):81-95. PubMed ID: 9542660 [No Abstract] [Full Text] [Related]
58. Morbidity and Mortality Associated With Anogenital Human Papillomavirus "Low Risk" Genotypes. Lacey CJ Sex Transm Dis; 2015 Oct; 42(10):545-6. PubMed ID: 26366506 [No Abstract] [Full Text] [Related]
59. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. Jenison SA; Firzlaff JM; Langenberg A; Galloway DA J Virol; 1988 Jun; 62(6):2115-23. PubMed ID: 2835513 [TBL] [Abstract][Full Text] [Related]
60. [Multiple papilloma virus particles in perianal condylomata acuminata of a drug-dependent patient]. Gross G Hautarzt; 1984 Feb; 35(2):84-7. PubMed ID: 6323350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]